Abstract: Oral and parenteral dosage forms comprising halofuginone, including enteric-coated solid oral dosage forms, subcutaneous dosage forms and intravenous dosage forms, for administration to subjects in need thereof, e.g., subjects having been identified with musculoskeletal disorders, fibrotic diseases, malaria, or cancer are described herein.
Type:
Application
Filed:
March 29, 2013
Publication date:
March 26, 2015
Applicant:
HALO THERAPEUTICS, LLC.
Inventors:
Ernest D. Bush, Diane Mcguire, Marc B. Blaustein